Franck Mounioko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Franck Mounioko has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ornella Zong Minko
Bacteriology Laboratory, Medical Analysis Research Unit, Interdisciplinary Center of Medical Research of Franceville (CIRMF), BP 769 Franceville, Gabon 2. Molecular and Cellular Biology Laboratory, Microbiology Team (LABMC), Agrobiology Research Unit, Mas
4 shared publications - Rolande Mabika Mabika
Bacteriology Laboratory, Medical Analysis Research Unit, Interdisciplinary Center of Medical Research of Franceville (CIRMF), BP 769 Franceville, Gabon
4 shared publications - Jean Fabrice Yala
Bacteriology Laboratory, Medical Analysis Research Unit, Interdisciplinary Center of Medical Research of Franceville (CIRMF), Franceville, Gabon
3 shared publications - Evrard Mayombo Ngoussou
Laboratoire de Bactériologie Unité de Recherche d’Analyses Médicales, Centre Interdisciplinaire de Recherches Médicales de Franceville, BP: 769, Franceville, Gabon
2 shared publications Léonce Fauster Ondjiangui
Laboratoire de Bactériologie Unité de Recherche d’Analyses Médicales, Centre Interdisciplinaire de Recherches Médicales de Franceville, BP: 769, Franceville, Gabon
2 shared publications- Rachel Moyen
Laboratoire de Biologie Moléculaire et Cellulaire, Faculté de Sciences et Techniques, Université Marien Ngouabi, BP: 69, Brazzaville, Republic of Congo
2 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (8) , 002190
Characterization of resistance to last-line therapeutic molecules and genetic diversity of Klebsiella spp. strains involved in urinary tract infections in women: the case of Hôpital d’Instruction des Armées Omar Bongo Ondimba
Introduction. Klebsiella spp. are the second most common uropathogens after Escherichia coli and are globally recognized for their high morbidity, driven by their significant ability to develop multi-drug resistance against a wide range of antimicrobials. Hypothesis/Gap Statement. In Central Africa, and particularly in Gabon, there is a significant lack of data regarding the prevalence and genetic diversity of uropathogenic Klebsiella spp. resistant to last-line antibiotics involved in urinary tract infections (UTIs) in women. Aim. This study aims to characterize the resistance of Klebsiella spp. involved in UTIs in women to last-line therapeutic molecules and to explore their genetic diversity through enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) profiling. Methodology. The germs were isolated on Urilines biphasic slides. Identification and susceptibility profiles were performed using the API 20E, ATB Ur and VITEK ® 2 COMPACT. Molecular research of carbapenemase genes ( bla KPC , bla IMP and bla VIM ) and resistance to fosfomycin ( fos A, fos B, fos C, glpT and uhpT ) was made by conventional PCR, and genetic diversity was screened using ERIC-PCR. Results. Of 343 patients, 60.64% (208 out of 343) were women, with a prevalence of UTIs of 43.75% (91 out of 208). The involvement of Klebsiella spp. uropathogens was 29.03% (27 out of 93) against 53.76% (50 out of 93) of other enterobacteria. Klebsiella spp. strains showed high levels of resistance to third-generation cephalosporins (55.56%), fourth-generation cephalosporins and fosfomycin (40.74%), average levels of resistance to third-generation fluoroquinolones (25.92%) and low levels of resistance to carbapenems (7.41%). A total of 81.82% (18 out of 22) of Klebsiella spp. strains possess antibiotic resistance genes, bla KPC (40.0%) and fos A (36.0%), respectively. The study of genetic diversity by interpretation of ERIC-PCR profiles shows 19 distinct banding patterns and 2 repeated profiles, all divided into 9 clusters. Conclusion. Uropathogenic Klebsiella spp. isolated from women have high rates of resistance to last-line antibiotics, with the exception of imipenem. They exhibit diverse ERIC-PCR profiles and possess bla KPC and fos A. These findings provide important preliminary surveillance data for the region.
- 27 August 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (8) , 002190
Open AccessCharacterization of resistance to last-line therapeutic molecules and genetic diversity of Klebsiella spp. strains involved in urinary tract infections in women: the case of Hôpital d’Instruction des Armées Omar Bongo Ondimba
Introduction. Klebsiella spp. are the second most common uropathogens after Escherichia coli and are globally recognized for their high morbidity, driven by their significant ability to develop multi-drug resistance against a wide range of antimicrobials. Hypothesis/Gap Statement. In Central Africa, and particularly in Gabon, there is a significant lack of data regarding the prevalence and genetic diversity of uropathogenic Klebsiella spp. resistant to last-line antibiotics involved in urinary tract infections (UTIs) in women. Aim. This study aims to characterize the resistance of Klebsiella spp. involved in UTIs in women to last-line therapeutic molecules and to explore their genetic diversity through enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) profiling. Methodology. The germs were isolated on Urilines biphasic slides. Identification and susceptibility profiles were performed using the API 20E, ATB Ur and VITEK ® 2 COMPACT. Molecular research of carbapenemase genes ( bla KPC , bla IMP and bla VIM ) and resistance to fosfomycin ( fos A, fos B, fos C, glpT and uhpT ) was made by conventional PCR, and genetic diversity was screened using ERIC-PCR. Results. Of 343 patients, 60.64% (208 out of 343) were women, with a prevalence of UTIs of 43.75% (91 out of 208). The involvement of Klebsiella spp. uropathogens was 29.03% (27 out of 93) against 53.76% (50 out of 93) of other enterobacteria. Klebsiella spp. strains showed high levels of resistance to third-generation cephalosporins (55.56%), fourth-generation cephalosporins and fosfomycin (40.74%), average levels of resistance to third-generation fluoroquinolones (25.92%) and low levels of resistance to carbapenems (7.41%). A total of 81.82% (18 out of 22) of Klebsiella spp. strains possess antibiotic resistance genes, bla KPC (40.0%) and fos A (36.0%), respectively. The study of genetic diversity by interpretation of ERIC-PCR profiles shows 19 distinct banding patterns and 2 repeated profiles, all divided into 9 clusters. Conclusion. Uropathogenic Klebsiella spp. isolated from women have high rates of resistance to last-line antibiotics, with the exception of imipenem. They exhibit diverse ERIC-PCR profiles and possess bla KPC and fos A. These findings provide important preliminary surveillance data for the region.
- Open Access
- 4 March 2026
- Published by Bentham Science Publishers Ltd. in The Open Microbiology Journal
- Vol. 20 (1)
Molecular Typing Of Diarrheagenic Escherichia Coli Strains Isolated From Children Under Five Years Using ERIC-PCR in Koula-Moutou, Gabon
Introduction: Diarrheagenic Escherichia coli (DEC) are enteric pathogens responsible for diarrhea in children. The aim of this study was to assess the genetic diversity of DEC in children under five years of age in Koula-Moutou, a topic that has not been previously investigated in Gabon. Methods: A total of 41 DEC strains, previously isolated and characterized, were included in this study. Genetic diversity was assessed using the Enterobacterial Repetitive Intergenic Consensus-Polymerase Chain Reaction (ERIC-PCR) method. Results: The ERIC-PCR method enabled typing of 34 out of the 41 DEC isolates. These 34 strains were differentiated into 27 distinct ERIC-PCR genetic profiles, with fingerprints consisting of 1 to 6 bands ranging in size from 250 to 1700 bp. The profiles were grouped into 10 clusters with 90% similarity, each cluster containing between 1 and 7 strains. The DEC isolates from children exhibited diverse genetic profiles, indicating a high degree of genotypic polymorphism. Discussion: 27 different and repeated genetic profiles revealed, suggesting a great diversity of circulating clones, which present different resistance profiles, and which may make the treatment ineffective or inappropriate, reflecting the genetic evolution of DEC in this region of Gabon. Conclusion: ERIC-PCR is a simple and rapid method for assessing the genetic diversity of DEC. This study revealed significant genetic variation among DEC strains and demonstrated that ERIC-PCR is a valuable tool for epidemiological surveillance and health-related research.
- 4 March 2026
- Published by Bentham Science Publishers Ltd. in The Open Microbiology Journal
- Vol. 20 (1)
Open AccessMolecular Typing Of Diarrheagenic Escherichia Coli Strains Isolated From Children Under Five Years Using ERIC-PCR in Koula-Moutou, Gabon
Introduction: Diarrheagenic Escherichia coli (DEC) are enteric pathogens responsible for diarrhea in children. The aim of this study was to assess the genetic diversity of DEC in children under five years of age in Koula-Moutou, a topic that has not been previously investigated in Gabon. Methods: A total of 41 DEC strains, previously isolated and characterized, were included in this study. Genetic diversity was assessed using the Enterobacterial Repetitive Intergenic Consensus-Polymerase Chain Reaction (ERIC-PCR) method. Results: The ERIC-PCR method enabled typing of 34 out of the 41 DEC isolates. These 34 strains were differentiated into 27 distinct ERIC-PCR genetic profiles, with fingerprints consisting of 1 to 6 bands ranging in size from 250 to 1700 bp. The profiles were grouped into 10 clusters with 90% similarity, each cluster containing between 1 and 7 strains. The DEC isolates from children exhibited diverse genetic profiles, indicating a high degree of genotypic polymorphism. Discussion: 27 different and repeated genetic profiles revealed, suggesting a great diversity of circulating clones, which present different resistance profiles, and which may make the treatment ineffective or inappropriate, reflecting the genetic evolution of DEC in this region of Gabon. Conclusion: ERIC-PCR is a simple and rapid method for assessing the genetic diversity of DEC. This study revealed significant genetic variation among DEC strains and demonstrated that ERIC-PCR is a valuable tool for epidemiological surveillance and health-related research.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 3553027
Molecular Characterization and Antibiotic Resistance of Broad‐Spectrum β ‐Lactamase‐Producing Enterobacterales in Urinary Tract Infections in Libreville, Gabon
Background: The effectiveness of antibiotic therapy for urogenital tract infections (UTIs) is increasingly compromised by the global dissemination of extended‐spectrum β ‐lactamase‐producing Enterobacterales (ES β L‐En). This study aimed to assess the involvement of broad‐spectrum β ‐lactamase‐producing Enterobacterales (BS β L‐En) in UTIs and to establish their antibiotic susceptibility profile. Methods: A cross‐sectional study was conducted from October to December 2019 at the Army Training Hospital Omar Bongo Ondimba. All patients suspected of having a UTI were included. BS β L‐En isolates were recovered using MacConkey agar supplemented with cefotaxime. Phenotypic screening for β ‐lactamase (ES β L, AmpC, and carbapenemases) using specific phenotypic confirmatory disc diffusion test. Antimicrobial susceptibility was determined using the disk diffusion method and minimum inhibitory concentration (MIC) assays. The presence of resistance genes ( bla CTX-M , bla TEM , bla CARBA , bla IMP , mcr-1 and mcr-2 ) was investigated by polymerase chain reaction. Results: A total of 295 patients were enrolled, among whom 18.3% (54/295) had UTIs. Of the isolated uropathogens 74.1% were BS β L‐En. The predominant species were Enterobacter cloacae (8/54, 14.8%), Escherichia coli (6/54, 11.1%) and Kluyvera spp (5/54, 9.3%). Among 40 BS β L‐En isolates, 87.5% ( n = 35/40) were confirmed by molecular analysis. Notably 48.5% (17/35) harbored at least two bla genes, simultaneously. Fourteen isolates carried the bla CARBA and bla IMP genes, which in combination with the bla CTX-M and bla TEM . About 40.0% of the isolates (14/35) carried the bla CTX-M , 8.6% had the bla TEM (3/35), and 2.9% had the bla IMP ( n = 1/35). All urinary isolates were multidrug‐resistant (MDR), exhibiting high levels of β ‐lactamase production, with resistance rates of 81.6 % ± 0.16 % for first‐line antibiotics (e.g., β ‐lactams, fluoroquinolones) and 61.7 % ± 0.04 % for last‐resort antibiotics (e.g., imipenen, ertapenem, and colistin). The prevalence of carbapenem resistance genes was 44.1%, whereas no colistin resistance genes ( mcr ‐1 and mcr ‐2) were detected. Conclusion: This study highlights a high prevalence of multidrug‐resistant uropathogens producing BS β L, with significant resistance to both first‐line and last‐resort antibiotics.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 3553027
Open AccessMolecular Characterization and Antibiotic Resistance of Broad‐Spectrum β ‐Lactamase‐Producing Enterobacterales in Urinary Tract Infections in Libreville, Gabon
Background: The effectiveness of antibiotic therapy for urogenital tract infections (UTIs) is increasingly compromised by the global dissemination of extended‐spectrum β ‐lactamase‐producing Enterobacterales (ES β L‐En). This study aimed to assess the involvement of broad‐spectrum β ‐lactamase‐producing Enterobacterales (BS β L‐En) in UTIs and to establish their antibiotic susceptibility profile. Methods: A cross‐sectional study was conducted from October to December 2019 at the Army Training Hospital Omar Bongo Ondimba. All patients suspected of having a UTI were included. BS β L‐En isolates were recovered using MacConkey agar supplemented with cefotaxime. Phenotypic screening for β ‐lactamase (ES β L, AmpC, and carbapenemases) using specific phenotypic confirmatory disc diffusion test. Antimicrobial susceptibility was determined using the disk diffusion method and minimum inhibitory concentration (MIC) assays. The presence of resistance genes ( bla CTX-M , bla TEM , bla CARBA , bla IMP , mcr-1 and mcr-2 ) was investigated by polymerase chain reaction. Results: A total of 295 patients were enrolled, among whom 18.3% (54/295) had UTIs. Of the isolated uropathogens 74.1% were BS β L‐En. The predominant species were Enterobacter cloacae (8/54, 14.8%), Escherichia coli (6/54, 11.1%) and Kluyvera spp (5/54, 9.3%). Among 40 BS β L‐En isolates, 87.5% ( n = 35/40) were confirmed by molecular analysis. Notably 48.5% (17/35) harbored at least two bla genes, simultaneously. Fourteen isolates carried the bla CARBA and bla IMP genes, which in combination with the bla CTX-M and bla TEM . About 40.0% of the isolates (14/35) carried the bla CTX-M , 8.6% had the bla TEM (3/35), and 2.9% had the bla IMP ( n = 1/35). All urinary isolates were multidrug‐resistant (MDR), exhibiting high levels of β ‐lactamase production, with resistance rates of 81.6 % ± 0.16 % for first‐line antibiotics (e.g., β ‐lactams, fluoroquinolones) and 61.7 % ± 0.04 % for last‐resort antibiotics (e.g., imipenen, ertapenem, and colistin). The prevalence of carbapenem resistance genes was 44.1%, whereas no colistin resistance genes ( mcr ‐1 and mcr ‐2) were detected. Conclusion: This study highlights a high prevalence of multidrug‐resistant uropathogens producing BS β L, with significant resistance to both first‐line and last‐resort antibiotics.
- Open Access
- 1 January 2025
- Published by Wiley in BioMed Research International
- Vol. 2025 (1)
Descriptive Epidemiology of Klebsiella spp. Urinary Tract Infections in Central Africa
Objective: Urinary tract infections are the most common bacterial infections encountered in clinical practice. Among the pathogens responsible, bacteria of the Klebsiella spp. are the second most frequently isolated uropathogenic agents worldwide. These bacteria are constantly evolving, both epidemiologically and in terms of the development of antimicrobial resistance. In Central Africa, available data on the spread of Klebsiella spp. are mainly derived from isolated studies, making it difficult to obtain an overview of their epidemiology in the subregion. Consequently, these systematic review and meta‐analysis are aimed at estimating the pooled prevalence of urinary tract infections in Central Africa and to describe the epidemiology of the Klebsiella spp. strains responsible for these infections. Methods: Relevant articles were searched in the SCOPUS, PubMed, and Google Scholar databases. The study selection process was conducted in accordance with the PRISMA flowchart recommendations. Systematic review and meta‐analysis were used to summarize data on urinary tract infections. Prevalence was determined and visualized using a forest plot with R software Version 4.4.1. Also, finally, geographical mapping of the data distribution was carried out using QGIS software (Version 3.34.15‐Prizren). Result: Out of all the articles retrieved, 34 studies were deemed eligible for this analysis. The overall pooled prevalence of urinary tract infections in Central Africa was estimated at 28% (95% IC: 28, 29). The overall isolation rate of Klebsiella spp. responsible for urinary tract infections was 12% (95% IC: 11, 12). Analysis of the distribution of Klebsiella spp. isolation rates in urinary tract infections across Central Africa revealed variability by country, ranging from 10% to 25%. The species Klebsiella pneumoniae was the most frequently isolated, present in 96.15% of the studies. Furthermore, Klebsiella spp. strains responsible for urinary tract infections were predominantly identified in females, with an overall isolation rate of 82.23%, compared to 17.77% in males.
- 1 January 2025
- Published by Wiley in BioMed Research International
- Vol. 2025 (1)
Open AccessDescriptive Epidemiology of Klebsiella spp. Urinary Tract Infections in Central Africa
Objective: Urinary tract infections are the most common bacterial infections encountered in clinical practice. Among the pathogens responsible, bacteria of the Klebsiella spp. are the second most frequently isolated uropathogenic agents worldwide. These bacteria are constantly evolving, both epidemiologically and in terms of the development of antimicrobial resistance. In Central Africa, available data on the spread of Klebsiella spp. are mainly derived from isolated studies, making it difficult to obtain an overview of their epidemiology in the subregion. Consequently, these systematic review and meta‐analysis are aimed at estimating the pooled prevalence of urinary tract infections in Central Africa and to describe the epidemiology of the Klebsiella spp. strains responsible for these infections. Methods: Relevant articles were searched in the SCOPUS, PubMed, and Google Scholar databases. The study selection process was conducted in accordance with the PRISMA flowchart recommendations. Systematic review and meta‐analysis were used to summarize data on urinary tract infections. Prevalence was determined and visualized using a forest plot with R software Version 4.4.1. Also, finally, geographical mapping of the data distribution was carried out using QGIS software (Version 3.34.15‐Prizren). Result: Out of all the articles retrieved, 34 studies were deemed eligible for this analysis. The overall pooled prevalence of urinary tract infections in Central Africa was estimated at 28% (95% IC: 28, 29). The overall isolation rate of Klebsiella spp. responsible for urinary tract infections was 12% (95% IC: 11, 12). Analysis of the distribution of Klebsiella spp. isolation rates in urinary tract infections across Central Africa revealed variability by country, ranging from 10% to 25%. The species Klebsiella pneumoniae was the most frequently isolated, present in 96.15% of the studies. Furthermore, Klebsiella spp. strains responsible for urinary tract infections were predominantly identified in females, with an overall isolation rate of 82.23%, compared to 17.77% in males.